Oxygenta Pharmaceutical Ltd has postponed its scheduled Board Meeting. The meeting was originally to be held on Saturday, July 25, 2026, at the company's corporate office.
The meeting has been rescheduled to Monday, July 27, 2026, and will be held at the same location, the corporate office of the company.
The agenda for the meeting remains unchanged and includes the following items for the board's consideration and approval:
- The unaudited financial results for the quarter ended June 30, 2026.
- The Limited Review Report for the quarter ended June 30, 2026.
- Any other business permitted by the Chair.
This communication, dated July 24, 2026, is a formal intimation of this postponement sent to the Manager of BSE Limited for the exchange's information and records.
The letter is digitally signed by Kumkum Bajaj, who holds the position of Company Secretary & Compliance Officer (Membership No.: A76548) for Oxygenta Pharmaceutical Ltd.